“Body Contouring Devices and Procedures Market Report is set to have rapid growth due to the factors, such as quick adoption of technologically advanced products, high domestic income, and rise in demand for noninvasive procedures at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Body Contouring Devices and Procedures Market Forecast 2019-2029: By Device Type, By Procedure Type (Cellulite Treatment, Liposuction), By End Use, And Segment Forecasts

One of the major reason for increasing demand for body contouring devices and procedures is rising cases of obesity across the globe due to unhealthy lifestyle. The increased life expectancy resulting from the improved safety and efficacy of body contouring devices, besides their ease of use, cost-effective, and less painful has also resulted in the growth of the market. Moreover, initiatives, such as M&A and partnerships, undertaken by major companies for product research and distribution are also fuelling the market growth. The technological development in this segment will fuel its growth.

The market is divided into segments of non-invasive and minimally invasive which holds the major share of the market. This segment also witness massive R&D by the key players which has enhanced safety, short downtimes, and cost-effectiveness of these devices and the procedures.

The clinics and spa centres are the major players in this segment owing to technologically advanced devices and reduced risks of hospital-acquired infections.

Leading companies featured in the report include: Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd., Bausch Health Companies, Inc., Lumenis, Merz Pharma, Meridian, InMode Aesthetic Solutions, El.En. S.p.A. (Asclepion Laser Technologies GmbH).

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever